Escherichia coli

Computer-generated image of the extended-spectrum ß-lactamase-producing Enterobacteriaceae bacteria, E. coli.
(Image: CDC)

Plasmodium falciparum

Placental tissue section revealing histopathology associated with a P. falciparum malarial infection.
(Image: CDC/Dr. Edwin P. Ewing, Jr.)

Human Respiratory Syncytial Virus

SEM of human respiratory syncytial virus (RSV) virions (blue) and labeled with anti-RSV F protein/gold antibodies (yellow).
(Image: NIAID)

Enterobacter

Four species of Enterobacteriaceae isolated from humans.
(Image: CDC)

Toxoplasma

Fluorescent antibody stained sample, revealed numerous Toxoplasma tachyzoites.
(Image: CDC)

Avian Influenza A H5N1

Transmission electron microscopic image of Avian Influenza A H5N1 viruses (gold), grown in Madin-Darby Canine Kidney epithelial cells (green).
(Image: CDC/Cynthia Goldsmith)

About GCID

The J. Craig Venter Institute (JCVI) Genomic Center for Infectious Diseases (GCID) was established by the National Institute for Allergy and Infectious Diseases (NIAID) to develop basic knowledge of infectious disease biology through the application of DNA sequencing, genotyping and comparative genome analysis.

The central theme of the JCVI GCID is the application of innovative genomics-based approaches to study pathogens and determinants of their virulence, drug-resistance, immune evasion and interactions with the host, and host microbiome to advance research in pathogenicity, drug-resistance, disease transmission and vaccine development.

Learn more.